Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$7.0 - $11.26 $2.61 Million - $4.2 Million
-372,905 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$7.61 - $9.46 $3.05 Million - $3.79 Million
400,142 New
400,142 $3.4 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $2.84 Million - $3.53 Million
-372,905 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$8.83 - $17.61 $3.53 Million - $7.05 Million
400,142 New
400,142 $3.66 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $4.35 Million - $8.02 Million
400,142 New
400,142 $4.57 Million
Q3 2022

Nov 13, 2023

BUY
$16.06 - $26.39 $5.99 Million - $9.84 Million
372,905 New
372,905 $6.35 Million
Q2 2022

Aug 14, 2023

BUY
$20.49 - $39.72 $7.64 Million - $14.8 Million
372,905 New
372,905 $8.01 Million
Q1 2022

May 12, 2023

SELL
$28.19 - $46.6 $8.65 Million - $14.3 Million
-307,021 Reduced 76.73%
93,121 $3.44 Million
Q1 2022

May 09, 2022

SELL
$28.19 - $46.6 $2.31 Million - $3.83 Million
-82,119 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$41.2 - $73.6 $3.38 Million - $6.04 Million
82,119 New
82,119 $3.74 Million
Q3 2021

Nov 14, 2022

BUY
$59.15 - $91.99 $4.29 Million - $6.67 Million
72,454 New
72,454 $4.59 Million
Q3 2021

Nov 05, 2021

SELL
$59.15 - $91.99 $12.8 Million - $19.8 Million
-215,777 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$63.02 - $95.11 $13.6 Million - $20.5 Million
215,777 New
215,777 $19.7 Million
Q2 2021

Aug 10, 2021

SELL
$63.02 - $95.11 $22.9 Million - $34.5 Million
-363,071 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$57.62 - $95.6 $20.9 Million - $34.7 Million
363,071 New
363,071 $24.7 Million
Q1 2021

May 07, 2021

SELL
$57.62 - $95.6 $1.04 Million - $1.72 Million
-18,004 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$41.43 - $77.09 $745,905 - $1.39 Million
18,004 New
18,004 $1.3 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.